Ignyta (RXDX) Tops Q3 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. BROS
4. EXPE
5. ARM
6. QCOM
7. DDOG
8. CPAY
9. CHYM
10. W

Go back to Ignyta (RXDX) Tops Q3 EPS by 11c

Ignyta Announces Third Quarter 2015 Company Highlights and Financial Results

November 9, 2015 7:30 AM EST

SAN DIEGO--(BUSINESS WIRE)-- Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced company highlights and financial results for the third quarter ended September 30, 2015.

Since the beginning of the third quarter of 2015, we have continued to make significant progress toward our objective of becoming a leading precision oncology biotechnology company that can provide patients with a variety of compelling cancer treatment options, said Jonathan Lim, M.D., Chairman and CEO of Ignyta. We continued to make strategic additions to our clinical pipeline that can help us eradicate residual disease in precisely defined... More